{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:03:50Z","timestamp":1768367030875,"version":"3.49.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-02027-w","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:46:28Z","timestamp":1767678388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-Coding RNAs as key regulators of interferon signaling in cancer immunotherapy: mechanistic insights and clinical prospects"],"prefix":"10.1007","volume":"26","author":[{"given":"Usamah","family":"Sayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed K.","family":"Abdulsahib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Renuka","family":"Jyothi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siya","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djamila","family":"Polatova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadhil Faez","family":"Sead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Akhavan-Sigari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"4","key":"2027_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/EBC20200032","volume":"65","author":"H Yan","year":"2021","unstructured":"Yan H, Bu P. Non-coding RNA in cancer. Essays Biochem. 2021;65(4):625\u201339.","journal-title":"Essays Biochem"},{"issue":"1","key":"2027_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5\u201318.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2027_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s11658-022-00317-9","volume":"27","author":"A Letafati","year":"2022","unstructured":"Letafati A, et al. MicroRNA let-7 and viral infections: focus on mechanisms of action. Cell Mol Biol Lett. 2022;27(1):14.","journal-title":"Cell Mol Biol Lett"},{"key":"2027_CR4","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fmicb.2020.01853","volume":"11","author":"JS Nahand","year":"2020","unstructured":"Nahand JS, et al. Circular rnas: new epigenetic signatures in viral infections. Front Microbiol. 2020;11:1853.","journal-title":"Front Microbiol"},{"key":"2027_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.omtn.2021.03.011","volume":"24","author":"JS Nahand","year":"2021","unstructured":"Nahand JS, et al. Cell death pathways and viruses: role of MicroRNAs. Mol Therapy Nucleic Acids. 2021;24:487\u2013511.","journal-title":"Mol Therapy Nucleic Acids"},{"key":"2027_CR6","doi-asserted-by":"crossref","unstructured":"Wang M, Yu F, Li P. Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications. Front Immunol, 2023. Volume 14\u20132023.","DOI":"10.3389\/fimmu.2023.1268745"},{"issue":"1","key":"2027_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-020-0194-y","volume":"5","author":"L Liu","year":"2020","unstructured":"Liu L, et al. Noncoding rnas: the shot callers in tumor immune escape. Signal Transduct Target Therapy. 2020;5(1):102.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"2027_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-024-02081-0","volume":"23","author":"M Bayat","year":"2024","unstructured":"Bayat M, Sadri Nahand J. Exosomal mirnas: the tumor\u2019s Trojan horse in selective metastasis. Mol Cancer. 2024;23(1):167.","journal-title":"Mol Cancer"},{"key":"2027_CR9","doi-asserted-by":"crossref","unstructured":"Rahimian N. Exosomal microRNA profiling. In: MicroRNA profiling: methods and protocols. 2022. p. 13\u201347.","DOI":"10.1007\/978-1-0716-2823-2_2"},{"key":"2027_CR10","doi-asserted-by":"crossref","unstructured":"Sadri Nahand J, Salmaninejad A, Mollazadeh S, et al. Virus, exosome, and microRNA: new insights into autophagy. In: Kaviani M, Azizi H, editors. Stem Cells in Tissue Differentiation, Regulation and Disease. Advances in Experimental Medicine and Biology, vol 1401. Springer; 2022. p. 97\u2013162. doi:10.1007\/5584_2022_715","DOI":"10.1007\/5584_2022_715"},{"key":"2027_CR11","doi-asserted-by":"publisher","first-page":"1567459","DOI":"10.3389\/fimmu.2025.1567459","volume":"16","author":"M Bayat","year":"2025","unstructured":"Bayat M, et al. Interferon and immunity: the role of MicroRNA in viral evasion strategies. Front Immunol. 2025;16:1567459.","journal-title":"Front Immunol"},{"issue":"1","key":"2027_CR12","doi-asserted-by":"publisher","first-page":"1929005","DOI":"10.1080\/2162402X.2021.1929005","volume":"10","author":"X Zhang","year":"2021","unstructured":"Zhang X, et al. Double-edged effects of interferons on the regulation of cancer-immunity cycle. Oncoimmunology. 2021;10(1):1929005.","journal-title":"Oncoimmunology"},{"issue":"3","key":"2027_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrc.2016.14","volume":"16","author":"BS Parker","year":"2016","unstructured":"Parker BS, Rautela J, Hertzog PJ. Antitumour actions of interferons: implications for cancer therapy. Nat Rev Cancer. 2016;16(3):131\u201344.","journal-title":"Nat Rev Cancer"},{"key":"2027_CR14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143296","author":"M von Locquenghien","year":"2021","unstructured":"von Locquenghien M, Rozal\u00e9n C, Celi\u00e0-Terrassa T. Interferons in cancer immunoediting: sculpting metastasis and immunotherapyresponse. J Clin Invest. 2021;131(1):e143296. https:\/\/doi.org\/10.1172\/JCI143296.","journal-title":"J Clin Invest"},{"issue":"1","key":"2027_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trecan.2022.09.003","volume":"9","author":"H Cheon","year":"2023","unstructured":"Cheon H, et al. How cancer cells make and respond to interferon-I. Trends Cancer. 2023;9(1):83\u201392.","journal-title":"Trends Cancer"},{"issue":"1","key":"2027_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","volume":"8","author":"D Jorgovanovic","year":"2020","unstructured":"Jorgovanovic D, et al. Roles of IFN-\u03b3 in tumor progression and regression: a review. Biomark Res. 2020;8(1):49.","journal-title":"Biomark Res"},{"issue":"1","key":"2027_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12935-024-03293-6","volume":"24","author":"A Zabeti Touchaei","year":"2024","unstructured":"Zabeti Touchaei A, Vahidi S. MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1\/PD-L1 and CTLA-4 pathways. Cancer Cell Int. 2024;24(1):102.","journal-title":"Cancer Cell Int"},{"key":"2027_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031737","author":"JL Garc\u00eda-Gim\u00e9nez","year":"2024","unstructured":"Garc\u00eda-Gim\u00e9nez JL, Saadi W, Ortega AL, et al. miRNAs related to immune checkpoint inhibitor response: a systematic review. Int JMol Sci. 2024;25(3):1737. https:\/\/doi.org\/10.3390\/ijms25031737.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2027_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Therapy. 2024;9(1):55.","journal-title":"Signal Transduct Target Therapy"},{"key":"2027_CR20","doi-asserted-by":"publisher","first-page":"1191913","DOI":"10.3389\/fonc.2023.1191913","volume":"13","author":"DT Zhan","year":"2023","unstructured":"Zhan DT, Xian HC. Exploring the regulatory role of LncRNA in cancer immunity. Front Oncol. 2023;13:1191913.","journal-title":"Front Oncol"},{"key":"2027_CR21","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.2147\/IJN.S461289","volume":"19","author":"R Han","year":"2024","unstructured":"Han R, et al. Synergistic immunoregulation: Harnessing circrnas and PiRNAs to amplify PD-1\/PD-L1 Inhibition therapy. Int J Nanomed. 2024;19:4803\u201334.","journal-title":"Int J Nanomed"},{"key":"2027_CR22","doi-asserted-by":"publisher","first-page":"216219","DOI":"10.1016\/j.canlet.2023.216219","volume":"564","author":"LL Yu","year":"2023","unstructured":"Yu LL, et al. CircRNAs in tumor immunity and immunotherapy: perspectives from innate and adaptive immunity. Cancer Lett. 2023;564:216219.","journal-title":"Cancer Lett"},{"key":"2027_CR23","doi-asserted-by":"publisher","first-page":"105730","DOI":"10.1016\/j.phrs.2021.105730","volume":"170","author":"JS Nahand","year":"2021","unstructured":"Nahand JS, et al. Oncogenic viruses and chemoresistance: what do we know? Pharmacol Res. 2021;170:105730.","journal-title":"Pharmacol Res"},{"issue":"6","key":"2027_CR24","doi-asserted-by":"publisher","first-page":"189179","DOI":"10.1016\/j.bbcan.2024.189179","volume":"1879","author":"M Bayat","year":"2024","unstructured":"Bayat M, et al. War or peace: viruses and metastasis. Biochim Et Biophys Acta (BBA)-Reviews Cancer. 2024;1879(6):189179\u2013p.","journal-title":"Biochim Et Biophys Acta (BBA)-Reviews Cancer"},{"key":"2027_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22598","author":"ZS Amjad","year":"2023","unstructured":"Amjad ZS, Shojaeian A, Sadri Nahand J, et al. Oncoviruses: induction of cancer development and metastasis by increasing anoikisresistance. Heliyon. 2023;9(12):e22598. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22598.","journal-title":"Heliyon"},{"issue":"6","key":"2027_CR26","doi-asserted-by":"publisher","first-page":"p189189","DOI":"10.1016\/j.bbcan.2024.189189","volume":"1879","author":"S Mohamadi","year":"2024","unstructured":"Mohamadi S, et al. The tumor microenvironment\u2019s gambit: Exosomal pawns on the board of head and neck cancer. Biochim Et Biophys Acta (BBA)-Reviews Cancer. 2024;1879(6):p189189.","journal-title":"Biochim Et Biophys Acta (BBA)-Reviews Cancer"},{"key":"2027_CR27","doi-asserted-by":"crossref","unstructured":"Bayat M, Shahabi P, Rezaei T, et al. Exosomal regulation of cellular reprogramming and polarization in the tumor microenvironment.Cancer Cell Int. 2025;25:04105.","DOI":"10.1186\/s12935-025-04105-1"},{"key":"2027_CR28","doi-asserted-by":"publisher","unstructured":"Bayat M, Nahand JS. Battlegrounds of treatment resistance: decoding the tumor microenvironment. Naunyn-Schmiedebergs Arch Pharmacol. 2025(9). https:\/\/doi.org\/10.1007\/s00210-025-04055-5.","DOI":"10.1007\/s00210-025-04055-5"},{"key":"2027_CR29","doi-asserted-by":"crossref","unstructured":"Mirzaei H et al. MicroRNA Biogenesis and Function, in Exosomes and MicroRNAs in Biomedical Science, H. Mirzaei, Editors. 2022, Springer International Publishing: Cham. pp. 1\u20139.","DOI":"10.1007\/978-3-031-79177-2_1"},{"issue":"1","key":"2027_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12935-023-03022-5","volume":"23","author":"M Eslami","year":"2023","unstructured":"Eslami M, et al. Mirna-related metastasis in oral cancer: moving and shaking. Cancer Cell Int. 2023;23(1):182.","journal-title":"Cancer Cell Int"},{"key":"2027_CR31","doi-asserted-by":"crossref","unstructured":"Mirzaei H. MicroRNAs in non-malignant diseases. In: Exosomes and MicroRNAs in Biomedical Science. Springer; 2022. p. 41\u201368.","DOI":"10.1007\/978-3-031-79177-2_3"},{"key":"2027_CR32","doi-asserted-by":"crossref","unstructured":"Mirzaei H. Exosomes. In: Exosomes and MicroRNAs in Biomedical Science. Springer; 2022. p. 79\u201392.","DOI":"10.1007\/978-3-031-79177-2_5"},{"issue":"3","key":"2027_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1158\/2159-8290.CD-19-0608","volume":"10","author":"JB Fan","year":"2020","unstructured":"Fan JB, et al. Type I interferon regulates a coordinated gene network to enhance cytotoxic T Cell-Mediated tumor killing. Cancer Discov. 2020;10(3):382\u201393.","journal-title":"Cancer Discov"},{"key":"2027_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev-pathol-031920-093932","volume":"16","author":"GM Boukhaled","year":"2021","unstructured":"Boukhaled GM, Harding S, Brooks DG. Opposing roles of type I interferons in cancer immunity. Annu Rev Pathol. 2021;16:167\u201398.","journal-title":"Annu Rev Pathol"},{"key":"2027_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031337","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Qin H, Li H, et al. The functional roles of ISG15\/ISGylation in cancer. Molecules. 2023;28(3):1337. https:\/\/doi.org\/10.3390\/molecules28031337.","journal-title":"Molecules"},{"issue":"2","key":"2027_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1053\/j.seminoncol.2014.02.002","volume":"41","author":"H Cheon","year":"2014","unstructured":"Cheon H, Borden EC, Stark GR. Interferons and their stimulated genes in the tumor microenvironment. Semin Oncol. 2014;41(2):156\u201373.","journal-title":"Semin Oncol"},{"issue":"3","key":"2027_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.7150\/ijms.39823","volume":"17","author":"HV Tong","year":"2020","unstructured":"Tong HV, et al. Upregulation of enzymes involved in isgylation and ubiquitination in patients with hepatocellular carcinoma. Int J Med Sci. 2020;17(3):347\u201353.","journal-title":"Int J Med Sci"},{"issue":"21","key":"2027_CR38","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1016\/j.jmb.2019.03.013","volume":"431","author":"JV Dzimianski","year":"2019","unstructured":"Dzimianski JV, et al. ISG15: it\u2019s complicated. J Mol Biol. 2019;431(21):4203\u201316.","journal-title":"J Mol Biol"},{"issue":"45","key":"2027_CR39","doi-asserted-by":"publisher","first-page":"74393","DOI":"10.18632\/oncotarget.11911","volume":"7","author":"C Zuo","year":"2016","unstructured":"Zuo C, et al. ISG15 in the tumorigenesis and treatment of cancer: an emerging role in malignancies of the digestive system. Oncotarget. 2016;7(45):74393\u2013409.","journal-title":"Oncotarget"},{"issue":"6","key":"2027_CR40","doi-asserted-by":"publisher","first-page":"101042831771041","DOI":"10.1177\/1010428317710410","volume":"39","author":"C Zuo","year":"2017","unstructured":"Zuo C, et al. MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells. Tumor Biol. 2017;39(6):1010428317710410.","journal-title":"Tumor Biol"},{"issue":"1","key":"2027_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41416-021-01337-6","volume":"125","author":"Y Yan","year":"2021","unstructured":"Yan Y, et al. Interferon regulatory factor 1 (IRF-1) downregulates checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in hepatocellular carcinoma (HCC) cells. Br J Cancer. 2021;125(1):101\u201311.","journal-title":"Br J Cancer"},{"key":"2027_CR42","doi-asserted-by":"crossref","unstructured":"Narayan VM, et al. Let-7f MicroRNA expression within established bladder cancer subtypes and upregulation with Recombinant interferon-alpha. American Society of Clinical Oncology; 2019.","DOI":"10.1200\/JCO.2019.37.7_suppl.462"},{"issue":"12","key":"2027_CR43","doi-asserted-by":"publisher","first-page":"e81366","DOI":"10.1371\/journal.pone.0081366","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, et al. Interferon-\u03b2 induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells. PLoS One. 2013;8(12):e81366.","journal-title":"PLoS One"},{"issue":"2","key":"2027_CR44","doi-asserted-by":"publisher","first-page":"e0117035","DOI":"10.1371\/journal.pone.0117035","volume":"10","author":"L Mao","year":"2015","unstructured":"Mao L, et al. BANF1 is downregulated by IRF1-regulated microRNA-203 in cervical cancer. PLoS One. 2015;10(2):e0117035.","journal-title":"PLoS One"},{"issue":"1","key":"2027_CR45","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.canlet.2015.01.003","volume":"359","author":"L Yuan","year":"2015","unstructured":"Yuan L, et al. IFN-\u03b3-mediated IRF1\/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1. Cancer Lett. 2015;359(1):136\u201347.","journal-title":"Cancer Lett"},{"issue":"7","key":"2027_CR46","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/ncb3371","volume":"18","author":"C Baer","year":"2016","unstructured":"Baer C, et al. Suppression of microRNA activity amplifies IFN-\u03b3-induced macrophage activation and promotes anti-tumour immunity. Nat Cell Biol. 2016;18(7):790\u2013802.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"2027_CR47","first-page":"1470","volume":"40","author":"T Tanaka","year":"2012","unstructured":"Tanaka T, et al. Inhibition of cell viability by human IFN-\u03b2 is mediated by microRNA-431. Int J Oncol. 2012;40(5):1470\u20136.","journal-title":"Int J Oncol"},{"issue":"3","key":"2027_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.21873\/cgp.20252","volume":"18","author":"RK Nam","year":"2021","unstructured":"Nam RK, et al. MiR-139 induces an interferon-\u03b2 response in prostate cancer cells by binding to RIG-1. Cancer Genomics Proteomics. 2021;18(3):197\u2013206.","journal-title":"Cancer Genomics Proteomics"},{"key":"2027_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-10-41","volume":"10","author":"MJ Schmitt","year":"2012","unstructured":"Schmitt MJ, et al. Interferon-\u03b3-induced activation of signal transducer and activator of transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. Cell Communication Signal. 2012;10:1\u201314.","journal-title":"Cell Communication Signal"},{"issue":"2","key":"2027_CR50","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1038\/cddis.2013.11","volume":"4","author":"S Noguchi","year":"2013","unstructured":"Noguchi S, et al. socs7, a target gene of microRNA-145, regulates interferon-\u03b2 induction through STAT3 nuclear translocation in bladder cancer cells. Cell Death Dis. 2013;4(2):e482\u2013482.","journal-title":"Cell Death Dis"},{"issue":"8","key":"2027_CR51","doi-asserted-by":"publisher","first-page":"12086","DOI":"10.18632\/aging.202915","volume":"13","author":"J Lei","year":"2021","unstructured":"Lei J, et al. Interferon regulatory factor transcript levels correlate with clinical outcomes in human glioma. Aging. 2021;13(8):12086\u201398.","journal-title":"Aging"},{"issue":"8","key":"2027_CR52","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.4161\/onci.22475","volume":"1","author":"H Yanai","year":"2012","unstructured":"Yanai H, Negishi H, Taniguchi T. The IRF family of transcription factors: inception, impact and implications in oncogenesis. Oncoimmunology. 2012;1(8):1376\u201386.","journal-title":"Oncoimmunology"},{"key":"2027_CR53","doi-asserted-by":"publisher","first-page":"p7948898","DOI":"10.1155\/2022\/7948898","volume":"2022","author":"X Lu","year":"2022","unstructured":"Lu X, et al. A comprehensive analysis of interferon regulatory factor expression: correlation with immune cell infiltration and patient prognosis in endometrial carcinoma. Biomed Res Int. 2022;2022:p7948898.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2027_CR54","doi-asserted-by":"publisher","first-page":"189061","DOI":"10.1016\/j.bbcan.2023.189061","volume":"1879","author":"BK Roberts","year":"2024","unstructured":"Roberts BK, Collado G, Barnes BJ. Role of interferon regulatory factor 5 (IRF5) in tumor progression: prognostic and therapeutic potential. Biochim Biophys Acta Rev Cancer. 2024;1879(1):189061.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"4","key":"2027_CR55","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s10238-022-00968-0","volume":"23","author":"R Maffei","year":"2023","unstructured":"Maffei R, et al. The dynamic functions of IRF4 in B cell malignancies. Clin Exp Med. 2023;23(4):1171\u201380.","journal-title":"Clin Exp Med"},{"issue":"10","key":"2027_CR56","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.it.2008.07.006","volume":"29","author":"R Lu","year":"2008","unstructured":"Lu R. Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol. 2008;29(10):487\u201392.","journal-title":"Trends Immunol"},{"issue":"1","key":"2027_CR57","doi-asserted-by":"publisher","first-page":"35521","DOI":"10.1038\/srep35521","volume":"6","author":"J Mahnke","year":"2016","unstructured":"Mahnke J, et al. Interferon regulatory factor 4 controls TH1 cell effector function and metabolism. Sci Rep. 2016;6(1):35521.","journal-title":"Sci Rep"},{"issue":"1","key":"2027_CR58","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3892\/ijmm.2016.2612","volume":"38","author":"F Liu","year":"2016","unstructured":"Liu F, et al. Upregulation of microRNA-450 inhibits the progression of lung cancer in vitro and in vivo by targeting interferon regulatory factor 2. Int J Mol Med. 2016;38(1):283\u201390.","journal-title":"Int J Mol Med"},{"issue":"5","key":"2027_CR59","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/jpp\/rgab009","volume":"73","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Interferon regulatory factor 6 correlates with the progression of non-small cell lung cancer and can be regulated by miR-320. J Pharm Pharmacol. 2021;73(5):682\u201391.","journal-title":"J Pharm Pharmacol"},{"issue":"11","key":"2027_CR60","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/leu.2015.124","volume":"29","author":"E Morelli","year":"2015","unstructured":"Morelli E, et al. Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo. Leukemia. 2015;29(11):2173\u201383.","journal-title":"Leukemia"},{"issue":"3","key":"2027_CR61","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.bbrc.2012.12.097","volume":"431","author":"F Gao","year":"2013","unstructured":"Gao F, et al. miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 2013;431(3):610\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"2027_CR62","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","volume":"76","author":"AA Svoronos","year":"2016","unstructured":"Svoronos AA, Engelman DM, Slack FJ. OncomiR or tumor suppressor? The duplicity of MicroRNAs in cancer. Cancer Res. 2016;76(13):3666\u201370.","journal-title":"Cancer Res"},{"key":"2027_CR63","doi-asserted-by":"publisher","first-page":"708765","DOI":"10.3389\/fonc.2021.708765","volume":"11","author":"K Otmani","year":"2021","unstructured":"Otmani K, Lewalle P. Tumor suppressor MiRNA in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications. Front Oncol. 2021;11:708765.","journal-title":"Front Oncol"},{"issue":"1","key":"2027_CR64","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12935-025-03786-y","volume":"25","author":"M Taghizadieh","year":"2025","unstructured":"Taghizadieh M, et al. To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death. Cancer Cell Int. 2025;25(1):153.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2027_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167500","volume":"1871","author":"MM Kesheh","year":"2025","unstructured":"Kesheh MM, Bayat M, Kobravi S, et al. MicroRNAs and human viral diseases: a focus on the role of microRNA-29. Biochim BiophysActa Mol Basis Dis. 2025;1871(1):167500.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"1","key":"2027_CR66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12950-024-00417-7","volume":"21","author":"H Bannazadeh Baghi","year":"2024","unstructured":"Bannazadeh Baghi H, et al. Regulatory role of MicroRNAs in virus-mediated inflammation. J Inflamm. 2024;21(1):43.","journal-title":"J Inflamm"},{"issue":"10","key":"2027_CR67","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/sj.bjc.6605958","volume":"103","author":"Y Tomimaru","year":"2010","unstructured":"Tomimaru Y, et al. MicroRNA-21 induces resistance to the anti-tumour effect of interferon-\u03b1\/5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer. 2010;103(10):1617\u201326.","journal-title":"Br J Cancer"},{"issue":"12","key":"2027_CR68","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1158\/1541-7786.MCR-09-0319","volume":"7","author":"M Ohno","year":"2009","unstructured":"Ohno M, et al. The modulation of MicroRNAs by type I IFN through the activation of signal transducers and activators of transcription 3 in human glioma. Mol Cancer Res. 2009;7(12):2022\u201330.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"2027_CR69","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3892\/or.2016.4864","volume":"36","author":"Y Yan","year":"2016","unstructured":"Yan Y, et al. MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells. Oncol Rep. 2016;36(2):633\u201340.","journal-title":"Oncol Rep"},{"issue":"4","key":"2027_CR70","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.bbrc.2011.09.124","volume":"414","author":"A Tomokuni","year":"2011","unstructured":"Tomokuni A, et al. miR-146a suppresses the sensitivity to interferon-\u03b1 in hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2011;414(4):675\u201380.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2027_CR71","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bbrc.2020.01.034","volume":"524","author":"K Dong","year":"2020","unstructured":"Dong K, et al. MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down-regulates the expression of interferon regulatory factor-1. Biochem Biophys Res Commun. 2020;524(2):273\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2027_CR72","unstructured":"Wan P-Q, et al. Analysis of the relationship between microRNA-31 and interferon regulatory factor-1 in hepatocellular carcinoma cells. Volume 24. European Review for Medical & Pharmacological Sciences; 2020. 2."},{"issue":"3","key":"2027_CR73","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jdermsci.2019.05.004","volume":"94","author":"X Li","year":"2019","unstructured":"Li X, et al. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2. J Dermatol Sci. 2019;94(3):330\u20138.","journal-title":"J Dermatol Sci"},{"issue":"5","key":"2027_CR74","doi-asserted-by":"publisher","first-page":"e2764","DOI":"10.1038\/cddis.2017.145","volume":"8","author":"C Liang","year":"2017","unstructured":"Liang C, et al. MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer. Cell Death Dis. 2017;8(5):e2764\u20132764.","journal-title":"Cell Death Dis"},{"issue":"6","key":"2027_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1685-z","volume":"10","author":"J Yuan","year":"2019","unstructured":"Yuan J, et al. MIR17HG-miR-18a\/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via Wnt\/\u03b2-catenin signalling. Cell Death Dis. 2019;10(6):454.","journal-title":"Cell Death Dis"},{"key":"2027_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176195","author":"L Jiang","year":"2020","unstructured":"Jiang L, Park MJ, Cho CJ, et al. ADAR1 suppresses interferon signaling in gastric cancer cells by microRNA-302a-mediatedIRF9\/STAT1 regulation. Int J Mol Sci. 2020;21(17):6195. https:\/\/doi.org\/10.3390\/ijms21176195.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2027_CR77","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/cpr.12223","volume":"48","author":"Y Li","year":"2015","unstructured":"Li Y, et al. Micro RNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF 7 expression. Cell Prolif. 2015;48(6):643\u20139.","journal-title":"Cell Prolif"},{"key":"2027_CR78","doi-asserted-by":"publisher","first-page":"1228458","DOI":"10.3389\/fimmu.2023.1228458","volume":"14","author":"A Farhana","year":"2023","unstructured":"Farhana A, et al. Gold nanoparticles attenuate the interferon-\u03b3 induced SOCS1 expression and activation of NF-\u03baB p65\/50 activity via modulation of microRNA-155-5p in triple-negative breast cancer cells. Front Immunol. 2023;14:1228458.","journal-title":"Front Immunol"},{"key":"2027_CR79","doi-asserted-by":"publisher","first-page":"7479","DOI":"10.2147\/OTT.S238975","volume":"13","author":"Y Shi","year":"2020","unstructured":"Shi Y, et al. miR-106b-5p inhibits IRF1\/IFN-\u03b2 signaling to promote M2 macrophage polarization of glioblastoma. Onco Targets Ther. 2020;13:7479\u201392.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"2027_CR80","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4049\/jimmunol.182.1.39","volume":"182","author":"D Yadav","year":"2009","unstructured":"Yadav D, et al. Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced MicroRNA. J Immunol. 2009;182(1):39\u201343.","journal-title":"J Immunol"},{"issue":"5","key":"2027_CR81","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1158\/0008-5472.CAN-07-5126","volume":"68","author":"T Xia","year":"2008","unstructured":"Xia T, et al. EBV MicroRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 2008;68(5):1436\u201342.","journal-title":"Cancer Res"},{"issue":"4","key":"2027_CR82","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.5808\/GI.2018.16.4.e18","volume":"16","author":"H Do","year":"2018","unstructured":"Do H, Kim W. Roles of oncogenic long Non-coding RNAs in cancer development. Genomics Inf. 2018;16(4):e18.","journal-title":"Genomics Inf"},{"issue":"3","key":"2027_CR83","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/ncb3473","volume":"19","author":"A Lin","year":"2017","unstructured":"Lin A, et al. The LINK-A LncRNA interacts with PtdIns(3,4,5)P(3) to hyperactivate AKT and confer resistance to AKT inhibitors. Nat Cell Biol. 2017;19(3):238\u201351.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2027_CR84","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s11658-022-00385-x","volume":"27","author":"R Li","year":"2022","unstructured":"Li R, et al. LncRNA PVT1: a novel oncogene in multiple cancers. Cell Mol Biol Lett. 2022;27(1):84.","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"2027_CR85","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.bbrc.2018.04.219","volume":"500","author":"H Ding","year":"2018","unstructured":"Ding H, et al. Long noncoding RNA PVT1 inhibits interferon-\u03b1 mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1. Biochem Biophys Res Commun. 2018;500(4):973\u201380.","journal-title":"Biochem Biophys Res Commun"},{"key":"2027_CR86","doi-asserted-by":"publisher","first-page":"663558","DOI":"10.3389\/fmed.2021.663558","volume":"8","author":"H Li","year":"2021","unstructured":"Li H, et al. Long non-coding RNA LINC00847 induced by E2F1 accelerates non-small cell lung cancer progression through targeting miR-147a\/IFITM1 axis. Front Med. 2021;8:663558.","journal-title":"Front Med"},{"key":"2027_CR87","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.omtn.2019.10.039","volume":"19","author":"H Wang","year":"2020","unstructured":"Wang H, et al. Long noncoding RNA LINC01116 contributes to gefitinib resistance in non-small cell lung cancer through regulating IFI44. Mol Therapy Nucleic Acids. 2020;19:218\u201327.","journal-title":"Mol Therapy Nucleic Acids"},{"issue":"2","key":"2027_CR88","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41419-023-05609-2","volume":"14","author":"Q Wang","year":"2023","unstructured":"Wang Q, et al. LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1\u2013TINCR-USP20-PD-L1 axis. Cell Death Dis. 2023;14(2):76.","journal-title":"Cell Death Dis"},{"issue":"5","key":"2027_CR89","first-page":"2205","volume":"25","author":"D Tong","year":"2020","unstructured":"Tong D, et al. IRF-1 mediated long non-coding RNA PVT1-214 promotes oxaliplatin resistance of colorectal cancer via miR-128 Inhibition. J Buon. 2020;25(5):2205\u201314.","journal-title":"J Buon"},{"key":"2027_CR90","doi-asserted-by":"publisher","first-page":"216463","DOI":"10.1016\/j.canlet.2023.216463","volume":"578","author":"L Du","year":"2023","unstructured":"Du L, et al. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p\/SOX4 axis and activating IFN\u03b3-JAK2-STAT1 pathway. Cancer Lett. 2023;578:216463.","journal-title":"Cancer Lett"},{"key":"2027_CR91","doi-asserted-by":"publisher","first-page":"156046","DOI":"10.1016\/j.prp.2025.156046","volume":"272","author":"X Liu","year":"2025","unstructured":"Liu X. The Paradoxical role of IFN-\u03b3 in cancer: balancing immune activation and immune evasion. Pathol Res Pract. 2025;272:156046.","journal-title":"Pathol Res Pract"},{"key":"2027_CR92","doi-asserted-by":"publisher","first-page":"1471100","DOI":"10.3389\/fmolb.2024.1471100","volume":"11","author":"KD Fischer","year":"2024","unstructured":"Fischer KD, et al. Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response. Front Mol Biosci. 2024;11:1471100.","journal-title":"Front Mol Biosci"},{"key":"2027_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110316","author":"B Lara","year":"2025","unstructured":"Lara B, Snyder M, Fimbres J, et al. The AhR regulates IFN-induced immune checkpoints in lung cancer cells through HNRNPH1, anRNA-binding protein, and INCR1, a novel long non-coding RNA. J Biol Chem. 2025;301(7):110316. https:\/\/doi.org\/10.1016\/j.jbc.2025.110316.","journal-title":"J Biol Chem"},{"issue":"1","key":"2027_CR94","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1038\/s41467-023-38252-8","volume":"14","author":"W Ma","year":"2023","unstructured":"Ma W, et al. Type I interferon response in astrocytes promotes brain metastasis by enhancing monocytic myeloid cell recruitment. Nat Commun. 2023;14(1):2632.","journal-title":"Nat Commun"},{"issue":"1","key":"2027_CR95","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1038\/s41598-024-56681-3","volume":"14","author":"Z-l Jing","year":"2024","unstructured":"Jing Z-l, et al. Interferon-\u03b3 in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells. Sci Rep. 2024;14(1):6053.","journal-title":"Sci Rep"},{"issue":"1","key":"2027_CR96","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.1038\/s41598-017-12414-3","volume":"7","author":"H Enomoto","year":"2017","unstructured":"Enomoto H, et al. The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis. Sci Rep. 2017;7(1):12189.","journal-title":"Sci Rep"},{"issue":"1","key":"2027_CR97","doi-asserted-by":"publisher","first-page":"28768","DOI":"10.1038\/s41598-024-80439-6","volume":"14","author":"C Zhang","year":"2024","unstructured":"Zhang C, Cui Y. Targeting TSPEAR-AS2 suppresses tumor growth and interferon signaling in esophageal cancer. Sci Rep. 2024;14(1):28768.","journal-title":"Sci Rep"},{"issue":"23","key":"2027_CR98","doi-asserted-by":"publisher","first-page":"12920","DOI":"10.3390\/ijms252312920","volume":"25","author":"H Nishiyama","year":"2024","unstructured":"Nishiyama H, et al. HOXA11-As promotes lymph node metastasis through regulation of IFNL and HMGB family genes in pancreatic cancer. Int J Mol Sci. 2024;25(23):12920.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2027_CR99","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000493967","volume":"50","author":"X-D Tang","year":"2018","unstructured":"Tang X-D, et al. LncRNA AFAP1-AS1 promotes migration and invasion of non-small cell lung cancer via up-regulating IRF7 and the RIG-I-like receptor signaling pathway. Cell Physiol Biochem. 2018;50(1):179\u201395.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"2027_CR100","doi-asserted-by":"publisher","first-page":"e1007578","DOI":"10.1371\/journal.ppat.1007578","volume":"15","author":"W Li","year":"2019","unstructured":"Li W, et al. Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1\/miR-218-5p network. PLoS Pathog. 2019;15(1):e1007578.","journal-title":"PLoS Pathog"},{"issue":"1","key":"2027_CR101","doi-asserted-by":"publisher","first-page":"20438","DOI":"10.1038\/s41598-021-99736-5","volume":"11","author":"Y Hatanaka","year":"2021","unstructured":"Hatanaka Y, et al. DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes. Sci Rep. 2021;11(1):20438.","journal-title":"Sci Rep"},{"key":"2027_CR102","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2019.05.038","volume":"459","author":"J Huang","year":"2019","unstructured":"Huang J, et al. Interferon-inducible LncRNA IRF1-AS represses esophageal squamous cell carcinoma by promoting interferon response. Cancer Lett. 2019;459:86\u201399.","journal-title":"Cancer Lett"},{"issue":"1","key":"2027_CR103","first-page":"1","volume":"12","author":"M Hajjari","year":"2015","unstructured":"Hajjari M, Salavaty A. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol Med. 2015;12(1):1\u20139.","journal-title":"Cancer Biol Med"},{"issue":"7","key":"2027_CR104","first-page":"1354","volume":"9","author":"MC Jiang","year":"2019","unstructured":"Jiang MC, et al. Emerging roles of LncRNA in cancer and therapeutic opportunities. Am J Cancer Res. 2019;9(7):1354\u201366.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"2027_CR105","doi-asserted-by":"publisher","first-page":"113438","DOI":"10.1016\/j.yexcr.2022.113438","volume":"422","author":"S Liu","year":"2023","unstructured":"Liu S, et al. Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-\u03b2\/STAT1 signaling. Exp Cell Res. 2023;422(2):113438.","journal-title":"Exp Cell Res"},{"issue":"2","key":"2027_CR106","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2016.08.024","volume":"382","author":"Y Wang","year":"2016","unstructured":"Wang Y, et al. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis. Cancer Lett. 2016;382(2):137\u201346.","journal-title":"Cancer Lett"},{"issue":"1","key":"2027_CR107","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12672-024-01134-6","volume":"15","author":"X Yin","year":"2024","unstructured":"Yin X, et al. LncRNA FLJ20021 regulates CDK1-mediated PANoptosis in a ZBP1-dependent manner to increase the sensitivity of laryngeal cancer-resistant cells to cisplatin. Discover Oncol. 2024;15(1):265.","journal-title":"Discover Oncol"},{"key":"2027_CR108","unstructured":"Xiao X-H, He S-Y. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a\/IRF-2 signaling pathway. Volume 24. European Review for Medical & Pharmacological Sciences; 2020. 6."},{"key":"2027_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1123-y","volume":"19","author":"H Ma","year":"2020","unstructured":"Ma H, et al. A novel IFN\u03b1-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma. Mol Cancer. 2020;19:1\u201316.","journal-title":"Mol Cancer"},{"key":"2027_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02142-0","volume":"21","author":"X Yin","year":"2021","unstructured":"Yin X, et al. LncRNA CTD-3252C9. 4 modulates pancreatic cancer cell survival and apoptosis through regulating IFI6 transcription. Cancer Cell Int. 2021;21:1\u201314.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2027_CR111","doi-asserted-by":"publisher","first-page":"12922","DOI":"10.1038\/s41598-018-31306-8","volume":"8","author":"G Jeong","year":"2018","unstructured":"Jeong G, et al. A Kelch domain-containing KLHDC7B and a long non-coding RNA ST8SIA6-AS1 act oppositely on breast cancer cell proliferation via the interferon signaling pathway. Sci Rep. 2018;8(1):12922.","journal-title":"Sci Rep"},{"issue":"2","key":"2027_CR112","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/1753425919827632","volume":"25","author":"P Fang","year":"2019","unstructured":"Fang P, et al. LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544\/RUNX3. Innate Immun. 2019;25(2):99\u2013109.","journal-title":"Innate Immun"},{"issue":"1","key":"2027_CR113","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41420-024-01997-2","volume":"10","author":"Z Wang","year":"2024","unstructured":"Wang Z, et al. NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53\/IRF1\/type I interferon signaling axis. Cell Death Discov. 2024;10(1):240.","journal-title":"Cell Death Discov"},{"key":"2027_CR114","doi-asserted-by":"publisher","first-page":"876660","DOI":"10.3389\/fonc.2022.876660","volume":"12","author":"C Liu","year":"2022","unstructured":"Liu C, et al. The interferon gamma-related long noncoding RNA signature predicts prognosis and indicates immune microenvironment infiltration in colon adenocarcinoma. Front Oncol. 2022;12:876660.","journal-title":"Front Oncol"},{"key":"2027_CR115","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3389\/fimmu.2014.00676","volume":"5","author":"H Kambara","year":"2015","unstructured":"Kambara H, et al. Regulation of interferon-stimulated gene BST2 by a LncRNA transcribed from a shared bidirectional promoter. Front Immunol. 2015;5:676.","journal-title":"Front Immunol"},{"issue":"11","key":"2027_CR116","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41388-022-02186-0","volume":"41","author":"W Zhang","year":"2022","unstructured":"Zhang W, et al. CircVPS13C promotes pituitary adenoma growth by decreasing the stability of IFITM1 mRNA via interacting with RRBP1. Oncogene. 2022;41(11):1550\u201362.","journal-title":"Oncogene"},{"issue":"1","key":"2027_CR117","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1038\/s41467-022-34872-8","volume":"13","author":"R Piras","year":"2022","unstructured":"Piras R, et al. CircCsnk1g3-and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment. Nat Commun. 2022;13(1):7243.","journal-title":"Nat Commun"},{"issue":"1","key":"2027_CR118","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s12885-021-08331-4","volume":"21","author":"Z-M Deng","year":"2021","unstructured":"Deng Z-M, et al. Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p\/IRF4 axis. BMC Cancer. 2021;21(1):583.","journal-title":"BMC Cancer"},{"issue":"11","key":"2027_CR119","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1002\/jcb.29620","volume":"121","author":"L Lin","year":"2020","unstructured":"Lin L, Cai J. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR\u20101299\u2010mediated IRF7 activation. J Cell Biochem. 2020;121(11):4377\u201385.","journal-title":"J Cell Biochem"},{"issue":"1","key":"2027_CR120","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/26895293.2021.1879279","volume":"14","author":"S Yuan","year":"2021","unstructured":"Yuan S, et al. CircRNA_100920 enhanced oncolytic adenovirus therapy in colon cancer by suppressing IFN-\u03b3 expression. All Life. 2021;14(1):102\u20139.","journal-title":"All Life"},{"issue":"2","key":"2027_CR121","doi-asserted-by":"publisher","first-page":"e1009294","DOI":"10.1371\/journal.ppat.1009294","volume":"17","author":"S Yao","year":"2021","unstructured":"Yao S, et al. CircRNA ARFGEF1 functions as a CeRNA to promote oncogenic KSHV-encoded viral interferon regulatory factor induction of cell invasion and angiogenesis by upregulating glutaredoxin 3. PLoS Pathog. 2021;17(2):e1009294.","journal-title":"PLoS Pathog"},{"issue":"1","key":"2027_CR122","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/jcmm.16105","volume":"25","author":"X Jiang","year":"2021","unstructured":"Jiang X, Chen D. Circular RNA hsa_circ_0000658 inhibits osteosarcoma cell proliferation and migration via the miR-1227\/IRF2 axis. J Cell Mol Med. 2021;25(1):510\u201320.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"2027_CR123","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1158\/1078-0432.CCR-22-3836","volume":"29","author":"N Ding","year":"2023","unstructured":"Ding N, et al. A tumor-suppressive molecular axis EP300\/circRERE\/miR-6837-3p\/MAVS activates type I IFN pathway and antitumor immunity to suppress colorectal cancer. Clin Cancer Res. 2023;29(11):2095\u2013109.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2027_CR124","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/0008-5472.CAN-18-2207","volume":"79","author":"U-G Lo","year":"2019","unstructured":"Lo U-G, et al. IFN\u03b3-induced IFIT5 promotes epithelial-to-mesenchymal transition in prostate cancer via MiRNA processing. Cancer Res. 2019;79(6):1098\u2013112.","journal-title":"Cancer Res"},{"issue":"15suppl","key":"2027_CR125","doi-asserted-by":"publisher","first-page":"e16522","DOI":"10.1200\/jco.2009.27.15_suppl.e16522","volume":"27","author":"D Reimer","year":"2009","unstructured":"Reimer D, et al. Regulation of the EGFR-E2F3a axis by the interferon regulatory factor (IRFs) and by promoter methylation of miR-34a in ovarian cancer. J Clin Oncol. 2009;27(15suppl):e16522\u201316522.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2027_CR126","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4049\/jimmunol.182.1.39","volume":"182","author":"D Yadav","year":"2009","unstructured":"Yadav D, et al. Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-\u03b3-induced MicroRNA. J Immunol. 2009;182(1):39\u201343.","journal-title":"J Immunol"},{"issue":"1","key":"2027_CR127","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13045-022-01394-1","volume":"15","author":"R Cuttano","year":"2022","unstructured":"Cuttano R, et al. Mirnome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response. J Hematol Oncol. 2022;15(1):178.","journal-title":"J Hematol Oncol"},{"key":"2027_CR128","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S238975","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zhang B, Zhu J, et al. miR-106b-5p inhibits IRF1\/IFN-\u03b2 signaling to promote M2 macrophage polarization of glioblastoma.Onco Targets Ther. 2020;13:7479\u20137492. https:\/\/doi.org\/10.2147\/OTT.S238975.","journal-title":"OncoTargets Ther"},{"issue":"6","key":"2027_CR129","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.4049\/jimmunol.1101235","volume":"187","author":"TX Lu","year":"2011","unstructured":"Lu TX, et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12\/IFN-\u03b3 pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol. 2011;187(6):3362\u201373.","journal-title":"J Immunol"},{"issue":"7","key":"2027_CR130","doi-asserted-by":"publisher","first-page":"e11794","DOI":"10.1371\/journal.pone.0011794","volume":"5","author":"G Wang","year":"2010","unstructured":"Wang G, et al. Signal transducers and activators of transcription-1 (STAT1) regulates microRNA transcription in interferon \u03b3-stimulated HeLa cells. PLoS One. 2010;5(7):e11794.","journal-title":"PLoS One"},{"issue":"1","key":"2027_CR131","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, et al. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduct Target Therapy. 2024;9(1):132.","journal-title":"Signal Transduct Target Therapy"},{"key":"2027_CR132","doi-asserted-by":"publisher","first-page":"p7869802","DOI":"10.1155\/2017\/7869802","volume":"2017","author":"N Carlomagno","year":"2017","unstructured":"Carlomagno N, et al. Diagnostic, Predictive, Prognostic, and therapeutic molecular biomarkers in third millennium: A breakthrough in gastric cancer. Biomed Res Int. 2017;2017:p7869802.","journal-title":"Biomed Res Int"},{"issue":"11","key":"2027_CR133","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s00018-022-04552-3","volume":"79","author":"N Ebrahimi","year":"2022","unstructured":"Ebrahimi N, et al. Tumor-derived Exosomal non-coding RNAs as diagnostic biomarkers in cancer. Cell Mol Life Sci. 2022;79(11):572.","journal-title":"Cell Mol Life Sci"},{"key":"2027_CR134","doi-asserted-by":"publisher","first-page":"710538","DOI":"10.3389\/fonc.2021.710538","volume":"11","author":"C Lu","year":"2021","unstructured":"Lu C, et al. Long Non-Coding RNAs as potential diagnostic and prognostic biomarkers in breast cancer: progress and prospects. Front Oncol. 2021;11:710538.","journal-title":"Front Oncol"},{"issue":"15","key":"2027_CR135","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1056\/NEJMoa0901282","volume":"361","author":"J Ji","year":"2009","unstructured":"Ji J, et al. Microrna expression, survival, and response to interferon in liver cancer. N Engl J Med. 2009;361(15):1437\u201347.","journal-title":"N Engl J Med"},{"key":"2027_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-10-241","volume":"10","author":"PL Triozzi","year":"2012","unstructured":"Triozzi PL, et al. The association of blood angioregulatory MicroRNA levels with Circulating endothelial cells and angiogenic proteins in patients receiving Dacarbazine and interferon. J Translational Med. 2012;10:1\u20137.","journal-title":"J Translational Med"},{"issue":"7","key":"2027_CR137","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/gutjnl-2015-310318","volume":"65","author":"Y Yang","year":"2016","unstructured":"Yang Y, et al. Interferon\u2013microrna signalling drives liver precancerous lesion formation and hepatocarcinogenesis. Gut. 2016;65(7):1186\u2013201.","journal-title":"Gut"},{"issue":"9","key":"2027_CR138","doi-asserted-by":"publisher","first-page":"e1425","DOI":"10.1002\/ctm2.1425","volume":"13","author":"M Alahdal","year":"2023","unstructured":"Alahdal M, Elkord E. Non-coding RNAs in cancer immunotherapy: predictive biomarkers and targets. Clin Transl Med. 2023;13(9):e1425.","journal-title":"Clin Transl Med"},{"issue":"22","key":"2027_CR139","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.7150\/jca.57477","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, et al. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a. J Cancer. 2021;12(22):6905.","journal-title":"J Cancer"},{"issue":"9","key":"2027_CR140","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/s41418-022-00970-9","volume":"29","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p\/MIOX axis as a CeRNA. Cell Death Differ. 2022;29(9):1850\u201363.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2027_CR141","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12943-019-1111-2","volume":"18","author":"PF Zhang","year":"2019","unstructured":"Zhang PF, et al. Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells. Mol Cancer. 2019;18(1):179.","journal-title":"Mol Cancer"},{"key":"2027_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102734","author":"JY Jung","year":"2021","unstructured":"Jung JY, Ryu HJ, Lee S-H, et al. siRNA nanoparticle targeting PD-L1 activates tumor immunity and abrogates pancreatic cancergrowth in humanized preclinical model. Cells. 2021;10(10):2734. https:\/\/doi.org\/10.3390\/cells10102734.","journal-title":"Cells"},{"issue":"4","key":"2027_CR143","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/ijms20040999","volume":"20","author":"L Xiang","year":"2019","unstructured":"Xiang L, Gilkes DM. The contribution of the immune system in bone metastasis pathogenesis. Int J Mol Sci. 2019;20(4):999.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2027_CR144","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12951-024-02485-6","volume":"22","author":"L Switala","year":"2024","unstructured":"Switala L, et al. Engineered nanoparticles promote cardiac tropism of AAV vectors. J Nanobiotechnol. 2024;22(1):223.","journal-title":"J Nanobiotechnol"},{"issue":"9","key":"2027_CR145","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/cancers11091270","volume":"11","author":"A Argentiero","year":"2019","unstructured":"Argentiero A, et al. Skeletal metastases of unknown primary: biological landscape and clinical overview. Cancers. 2019;11(9):1270.","journal-title":"Cancers"},{"issue":"9","key":"2027_CR146","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1111\/bph.14836","volume":"178","author":"M Puppo","year":"2021","unstructured":"Puppo M, et al. Non-coding RNAs in bone remodelling and bone metastasis: mechanisms of action and translational relevance. Br J Pharmacol. 2021;178(9):1936\u201354.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2027_CR147","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/cancers15010242","volume":"15","author":"M Puppo","year":"2022","unstructured":"Puppo M, et al. MiRNAs and snornas in bone metastasis: functional roles and clinical potential. Cancers. 2022;15(1):242.","journal-title":"Cancers"},{"issue":"3","key":"2027_CR148","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11914-019-00510-4","volume":"17","author":"E Hesse","year":"2019","unstructured":"Hesse E, Taipaleenmaeki H. MicroRNAs in bone metastasis. Curr Osteoporos Rep. 2019;17(3):122\u20138.","journal-title":"Curr Osteoporos Rep"},{"issue":"19","key":"2027_CR149","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1007\/s00018-019-03162-w","volume":"76","author":"D Bellavia","year":"2019","unstructured":"Bellavia D, et al. Deregulated MiRNAs in osteoporosis: effects in bone metastasis. Cell Mol Life Sci. 2019;76(19):3723\u201344.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2027_CR150","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jbo.2016.04.002","volume":"5","author":"E Zoni","year":"2016","unstructured":"Zoni E, van der Pluijm G. The role of MicroRNAs in bone metastasis. J Bone Oncol. 2016;5(3):104\u20138.","journal-title":"J Bone Oncol"},{"issue":"1","key":"2027_CR151","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/jgh.13041","volume":"31","author":"YJ Chen","year":"2016","unstructured":"Chen YJ, et al. MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients. J Gastroenterol Hepatol. 2016;31(1):155\u201363.","journal-title":"J Gastroenterol Hepatol"},{"issue":"17","key":"2027_CR152","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.3390\/ijms21176195","volume":"21","author":"L Jiang","year":"2020","unstructured":"Jiang L, et al. ADAR1 suppresses interferon signaling in gastric cancer cells by microRNA-302a-mediated IRF9\/STAT1 regulation. Int J Mol Sci. 2020;21(17):6195.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2027_CR153","first-page":"3261","volume":"40","author":"Y Liang","year":"2018","unstructured":"Liang Y, et al. miR\u201329a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3. Oncol Rep. 2018;40(6):3261\u201372.","journal-title":"Oncol Rep"},{"issue":"3","key":"2027_CR154","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3892\/ijo.2017.3852","volume":"50","author":"M Yu","year":"2017","unstructured":"Yu M, et al. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR\/STAT3\/AKT pathway in hepatocellular carcinoma. Int J Oncol. 2017;50(3):975\u201383.","journal-title":"Int J Oncol"},{"issue":"7","key":"2027_CR155","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7150\/ijms.44377","volume":"17","author":"J Li","year":"2020","unstructured":"Li J, et al. miR-19 regulates the expression of interferon-induced genes and MHC class I genes in human cancer cells. Int J Med Sci. 2020;17(7):953.","journal-title":"Int J Med Sci"},{"issue":"5","key":"2027_CR156","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3892\/ijo.2014.2317","volume":"44","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, et al. Downregulation of microRNA-431 by human interferon-\u03b2 inhibits viability of Medulloblastoma and glioblastoma cells via upregulation of SOCS6. Int J Oncol. 2014;44(5):1685\u201390.","journal-title":"Int J Oncol"},{"issue":"20","key":"2027_CR157","doi-asserted-by":"publisher","first-page":"8108","DOI":"10.1158\/0008-5472.CAN-10-2579","volume":"70","author":"CH Yang","year":"2010","unstructured":"Yang CH, et al. IFN induces miR-21 through a signal transducer and activator of transcription 3\u2013dependent pathway as a suppressive negative feedback on IFN-induced apoptosis. Cancer Res. 2010;70(20):8108\u201316.","journal-title":"Cancer Res"},{"key":"2027_CR158","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ncrna.2024.08.003","volume":"10","author":"H Xu","year":"2025","unstructured":"Xu H, et al. ADAR1-regulated miR-142-3p\/RIG-I axis suppresses antitumor immunity in nasopharyngeal carcinoma. Non-coding RNA Res. 2025;10:116\u201329.","journal-title":"Non-coding RNA Res"},{"key":"2027_CR159","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.biocel.2017.12.017","volume":"95","author":"J-j Jin","year":"2018","unstructured":"Jin J-j, et al. Overexpression of miR-1290 contributes to cell proliferation and invasion of Non small cell lung cancer by targeting interferon regulatory factor 2. Int J Biochem Cell Biol. 2018;95:113\u201320.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"2027_CR160","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3892\/ol.2020.12123","volume":"20","author":"JP Cheng","year":"2020","unstructured":"Cheng JP, et al. miR-4295 promotes cell proliferation, migration and invasion of osteosarcoma through targeting interferon regulatory factor 1. Oncol Lett. 2020;20(5):260.","journal-title":"Oncol Lett"},{"issue":"3","key":"2027_CR161","first-page":"3760","volume":"15","author":"G Ding","year":"2018","unstructured":"Ding G, et al. IFN-\u03b3 induces the upregulation of RFXAP via inhibition of miR-212-3p in pancreatic cancer cells: a novel mechanism for IFN-\u03b3 response. Oncol Lett. 2018;15(3):3760\u20135.","journal-title":"Oncol Lett"},{"issue":"23","key":"2027_CR162","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1016\/j.febslet.2014.10.004","volume":"588","author":"B Song","year":"2014","unstructured":"Song B, et al. miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I. FEBS Lett. 2014;588(23):4375\u201381.","journal-title":"FEBS Lett"},{"issue":"2","key":"2027_CR163","doi-asserted-by":"publisher","first-page":"152784","DOI":"10.1016\/j.prp.2019.152784","volume":"216","author":"Z Yan","year":"2020","unstructured":"Yan Z, et al. Screening and identification of epithelial-to-mesenchymal transition-related circrna and MiRNA in prostate cancer. Pathology-Research Pract. 2020;216(2):152784.","journal-title":"Pathology-Research Pract"},{"key":"2027_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102065","author":"M Akimoto","year":"2022","unstructured":"Akimoto M, Susa T, Okudaira N, et al. A novel lncRNA PTH-AS upregulates interferon-related DNA damage resistance signaturegenes and promotes metastasis in human breast cancer xenografts. J Biol Chem. 2022;298(7):102065. https:\/\/doi.org\/10.1016\/j.jbc.2022.102065.","journal-title":"J Biol Chem"},{"issue":"7","key":"2027_CR165","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1002\/cam4.1524","volume":"7","author":"J Huang","year":"2018","unstructured":"Huang J, et al. Long non-coding RNA GAS 5 is induced by interferons and plays an antitumor role in esophageal squamous cell carcinoma. Cancer Med. 2018;7(7):3157\u201367.","journal-title":"Cancer Med"},{"key":"2027_CR166","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2020_191014N1034","author":"M Wei","year":"2020","unstructured":"Wei MF, Gu ZS, Zheng LL, Zhao MX, Wang XJ. Long non-coding RNA GAS5 promotes natural killer cell cytotoxicity against gastriccancer by regulating miR-18a. Neoplasma. 2020;67(5):1085\u20131093. https:\/\/doi.org\/10.4149\/neo_2020_191014N1034.","journal-title":"Neoplasma"},{"key":"2027_CR167","doi-asserted-by":"publisher","first-page":"153856","DOI":"10.1016\/j.prp.2022.153856","volume":"233","author":"Y Xu","year":"2022","unstructured":"Xu Y, et al. Long noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN\/STAT1 signaling pathway. Pathology-Research Pract. 2022;233:153856.","journal-title":"Pathology-Research Pract"},{"key":"2027_CR168","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.omtn.2020.08.001","volume":"21","author":"L Yang","year":"2020","unstructured":"Yang L, et al. hsa_circ_0003738 inhibits the suppressive function of Tregs by targeting miR-562\/IL-17A and miR-490-5p\/IFN-\u03b3 signaling pathway. Mol Therapy-Nucleic Acids. 2020;21:1111\u20139.","journal-title":"Mol Therapy-Nucleic Acids"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-02027-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-02027-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-02027-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:17:21Z","timestamp":1768342641000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-02027-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":168,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2027"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-02027-w","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"During the development of this manuscript, the authors used artificial intelligence-based language tools, including DeepAI\u2019s ChatGPT, to improve grammar, clarity, and overall readability. All content generated with the assistance of these tools was thoroughly reviewed, revised, and adapted by the authors to ensure accuracy and originality. The final version of the work reflects the authors\u2019 independent analysis, critical thinking, and full responsibility for the presented content.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"101"}}